MorphoSys AG
MPSYF · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.26 | 0.04 | 0.00 | -0.16 |
| FCF Yield | -24.30% | -83.61% | -45.86% | -0.46% |
| EV / EBITDA | -17.46 | 2.28 | -7.31 | 25.56 |
| Quality | ||||
| ROIC | -14.13% | -65.73% | -10.62% | 35.53% |
| Gross Margin | 75.51% | 82.53% | 82.07% | 97.20% |
| Cash Conversion Ratio | 1.56 | 2.43 | 0.94 | 0.36 |
| Growth | ||||
| Revenue 3-Year CAGR | 9.88% | -5.30% | 35.77% | 62.45% |
| Free Cash Flow Growth | 21.79% | 24.76% | -3,508.50% | 83.21% |
| Safety | ||||
| Net Debt / EBITDA | -4.88 | -0.36 | -1.13 | 1.63 |
| Interest Coverage | -2.30 | 1.39 | -1.53 | 1.24 |
| Efficiency | ||||
| Inventory Turnover | 0.94 | 2.00 | 1.55 | 0.92 |
| Cash Conversion Cycle | 276.00 | 39.82 | -426.79 | -1,406.04 |